[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia- pacific Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

July 2018 | 100 pages | ID: A552FC3BA4CEN
Data Bridge Market Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Asia-Pacific wound care biologics market segment is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Asia-Pacific wound care biologics market are listed below:
  • MiMedx
  • Organogenesis Inc.
  • Integra LifeSciences
  • ConvaTec Inc.
  • Smith and Nephew
  • INTEGRA LIFE SCIENCES CORPORATION
  • Mölnlycke Health Care AB
The Asia-Pacific wound care biologics market is segmented into:
  • Product Type
  • Wound Type
  • End User
On the basis of product type the Asia-Pacific wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Asia-Pacific wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the Asia-Pacific wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Asia-Pacific wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user Asia-Pacific wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare. In 2018, hospitals are expected to dominate the Asia-Pacific wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into:
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific
Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION

1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-Pacific Wound Care Biologics Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.1 Dbmr Market Position Grid
2.2 Dbmr Market Challenge Matrix
2.3 Secondary Sources
2.4 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Increasing Cases Of Diabetic Foot Ulcers
  3.1.2 Increasing Incidences Of Burn Cases
  3.1.3 Rising Number Of Geriatric Population
  3.1.4 Innovation In Wound Care Biologics
  3.1.5 New Product Launches
3.2 Restrains
  3.2.1 High Cost Of Wound Treatment And Wound Care Biologics
  3.2.2 Risk Of Skin Substitue Failure
3.3 Opportunities
  3.3.1 3D Skin Printing
  3.3.2 Awareness Programs
3.4 Challenges
  3.4.1 Lack Of Wound Management Services

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Synthetic Skin Grafts
6.3 Growth Factors
  6.3.1 Platelet Derived Growth Factor (Pdgf)
  6.3.2 Platelet Rich Plasma (Prp)
  6.3.3 Epidermal Growth Factors (Egf)
  6.3.4 Basic Fibroblast Growth Factors (Bfgf)
  6.3.5 Granulocyte Colony Stimulating Factor (G-Csf)
  6.3.6 Talactoferrin Alfa
  6.3.7 Thrombin Peptide
  6.3.8 Keratinocy Growth Factor (Kgf)
6.4 Allografts
6.5 Xenografts

7 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE

7.1 Overview
7.2 Wounds
  7.2.1 Surgical Wound
    7.2.1.1 Skin Surgery
      7.2.1.1.1 Wound Closure
      7.2.1.1.2 Skin Biopsy
      7.2.1.1.3 Skin Flap
      7.2.1.1.4 Skin Graft
      7.2.1.1.5 Others
    7.2.1.2 Cosmetic Procedure
      7.2.1.2.1 Brest Enhancement
      7.2.1.2.2 Facial Contouring
      7.2.1.2.3 Facial Rejuvenation:
      7.2.1.2.4 Body Contouring
      7.2.1.2.5 Skin Rejuvenation
      7.2.1.2.6 Others
    7.2.1.3 Gynecologic Procedures
      7.2.1.3.1 Pubovaginalis Sling
      7.2.1.3.2 Pelvic Floor Reconstruction
      7.2.1.3.3 Rectocele Repair Surgery
      7.2.1.3.4 Others
    7.2.1.4 Gastrointestinal Procedure
      7.2.1.4.1 General Gastrointestinal Surgery
      7.2.1.4.2 Hernia
      7.2.1.4.3 Others
  7.2.2 Acute Wounds
  7.2.3 Chronic Wounds
  7.2.4 Traumatic Wounds
7.3 Burns
  7.3.1 Ulcers
  7.3.2 Diabetic Ulcers
  7.3.3 Pressure Ulcer
  7.3.4 Venous Ulcer
  7.3.5 Others

8 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY END USER

8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Surgical Centers
8.5 Clinics
8.6 Community Healthcare Center

9 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: GEOGRAPHY

9.1 Asia-Pacific
  9.1.1 China
  9.1.2 Japan
  9.1.3 India
  9.1.4 South Korea
  9.1.5 Australia
  9.1.6 Thailand
  9.1.7 Malaysia
  9.1.8 Singapore
  9.1.9 Indonesia
  9.1.10 Philippines
  9.1.11 Rest Of Asia-Pacific

10 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE

10.1 Company Share Analysis: Asia-Pacific

11 COMPANY PROFILE

11.1 Mimedx.
  11.1.1 Company Overview
  11.1.2 Revenue Analysis:
  11.1.3 Company Share Analysis:
  11.1.4 Product Portfolio
  11.1.5 Recent Developments
11.2 Organogenesis Inc
  11.2.1 Company Overview
  11.2.2 Geographic Presence
  11.2.3 Company Share Analysis:
  11.2.4 Product Portfolio
  11.2.5 Recent Developments
11.3 Integra Lifesciences
  11.3.1 Company Overview
  11.3.2 Revenue Analysis
  11.3.3 Company Share Analysis:
  11.3.4 Product Portfolio
  11.3.5 Recent Developments
11.4 Convatec Inc.
  11.4.1 Company Overview
  11.4.2 Revenue Analysis
  11.4.3 Company Share Analysis:
  11.4.4 Product Portfolio:
  11.4.5 Recent Developments
11.5 Acell Inc.
  11.5.1 Company Overview
  11.5.2 Product Portfolio
  11.5.3 Recent Developments
11.6 Allosource
  11.6.1 Company Overview
  11.6.2 Product Portfolio
  11.6.3 Recent Developments
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc)
  11.7.1 Company Overview
  11.7.2 Product Portfolio
  11.7.3 Recent Developments
11.8 Amnio Technology, Llc
  11.8.1 Company Overview
  11.8.2 Product Portfolio
  11.8.3 Recent Developments
11.9 Amniox Medical, Inc.
  11.9.1 Company Overview
  11.9.2 Product Portfolio
  11.9.3 Recent Developments
11.10 Anika Therapeutics, Inc.
  11.10.1 Company Overview
  11.10.2 Revenue Analysis
  11.10.3 Product Portfolio
  11.10.4 Recent Developments
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.)
  11.11.1 Company Overview
  11.11.2 Geographicpresence
  11.11.3 Product Portfolio
  11.11.4 Recent Developments
11.12 Kerecis
  11.12.1 Company Overview
  11.12.2 Geographical Presence
  11.12.3 Product Portfolio
  11.12.4 Recent Developments
11.13 Marine Polymer Technologies, Inc
  11.13.1 Company Overview
  11.13.2 Product Portfolio
  11.13.3 Recent Developments
11.14 Mölnlycke Health Care Ab
  11.14.1 Company Overview
  11.14.2 Revenue Analysis
  11.14.3 Product Portfolio
  11.14.4 Recent Developments
11.15 Osiris Therapeutics, Inc.
  11.15.1 Company Overview
  11.15.2 Revenue Analysis
  11.15.3 Product Portfolio
  11.15.4 Recent Developments
11.16 Skye Biologics Inc.
  11.16.1 Company Overview
  11.16.2 Product Portfolio:
  11.16.3 Recent Development:
11.17 Smith And Nephew
  11.17.1 Company Overview
  11.17.2 Revenue Analysis
  11.17.3 Product Portfolio
  11.17.4 Recent Developments
11.18 Solsys Medical.
  11.18.1 Company Overview
  11.18.2 Product Portfolio
  11.18.3 Recent Developments
11.19 Vericel Corporation.
  11.19.1 Company Overview
  11.19.2 1.1.2 Revenue Analysis
  11.19.3 Product Portfolio
  11.19.4 Recent Developments
11.20 Wright Medical Group N.V
  11.20.1 Company Overview
  11.20.2 1.1.2 Revenue Analysis
  11.20.3 Product Portfolio
  11.20.4 Recent Developments

12 RELATED REPORTS

LIST OF TABLES

Table 1 Asia-Pacific Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 2 Asia-Pacific Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 3 Asia-Pacific Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million)
Table 4 Asia-Pacific Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 5 Asia-Pacific Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 6 Asia-Pacific Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 7 Asia-Pacific Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million)
Table 8 Asia-Pacific Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 9 Asia-Pacific Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million)
Table 10 Asia-Pacific Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 11 Asia-Pacific Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million)
Table 12 Number Of Cosmetic Surgery, 2016 & 2017
Table 13 Asia-Pacific Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 14 Asia-Pacific Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million)
Table 15 Asia-Pacific Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million)
Table 16 Asia-Pacific Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 17 Asia-Pacific Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 18 Asia-Pacific Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million)
Table 19 Asia-Pacific Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million)
Table 20 Asia-Pacific Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 21 Asia-Pacific Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 22 Statistics For Ambulatory Surgical Center. U.S.
Table 23 Asia-Pacific Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 24 Asia-Pacific Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 25 Asia-Pacific Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million)
Table 26 Asia-Pacific Wound Care Biologics Market, By Country, 2016-2025, (Usd Million)
Table 27 Asia-Pacific Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 28 Asia-Pacific Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 29 Asia-Pacific Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 30 Asia-Pacific Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 31 Europe Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 32 Asia-Pacific Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 33 Asia-Pacific Cosmetic Procedures In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 34 Asia-Pacific Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 35 Asia-Pacific Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 36 Asia-Pacific Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 37 Asia-Pacific Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 38 China Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 39 China Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 40 China Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 41 China Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 42 China Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 43 China Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 44 China Cosmetic Procedures In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 45 China Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 46 China Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 47 China Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 48 China Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 49 Japan Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 50 Japan Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 51 Japan Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 52 Japan Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 53 Japan Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 54 Japan Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 55 Japan Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 56 Japan Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 57 Japan Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 58 Japan Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 59 Japan Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 60 India Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 61 India Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 62 India Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 63 India Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 64 India Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 65 India Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 66 India Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 67 India Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 68 India Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 69 India Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 70 India Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 71 South Korea Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 72 South Korea Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 73 South Korea Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 74 South Korea Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 75 South Korea Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 76 South Korea Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 77 South Korea Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 78 South Korea Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 79 South Korea Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 80 South Korea Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 81 South Korea Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 82 Australia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 83 Australia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 84 Australia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 85 Australia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 86 Australia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 87 Australia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 88 Australia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 89 Australia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 90 Australia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 91 Australia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 92 Australia Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 93 Thailand Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 94 Thailand Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 95 Thailand Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 96 Thailand Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 97 Thailand Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 98 Thailand Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 99 Thailand Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 100 Thailand Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 101 Thailand Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 102 Thailand Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 103 Thailand Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 104 Malaysia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 105 Malaysia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 106 Malaysia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 107 Malaysia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 108 Malaysia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 109 Malaysia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 110 Malaysia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 111 Malaysia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 112 Malaysia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 113 Malaysia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 114 Malaysia Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 115 Singapore Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 116 Singapore Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 117 Singapore Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 118 Singapore Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 119 Singapore Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 120 Singapore Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 121 Singapore Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 122 Singapore Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 123 Singapore Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 124 Singapore Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 125 Singapore Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 126 Indonesia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 127 Indonesia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 128 Indonesia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 129 Indonesia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 130 Indonesia Surgical Wounds In Wound Care Biologics, By Wound Type, “2016-2025, (Usd Million)
Table 131 Indonesia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 132 Indonesia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 133 Indonesia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 134 Philippinesgynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 135 Indonesia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 136 Indonesia Wound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 137 Philippines Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 138 Philippines Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)
Table 139 Philippines Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 140 Philippines Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 141 Philippines Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 142 Philippines Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 143 Philippines Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 144 Philippines Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 145 Philippinesgynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 146 Philippines Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million)
Table 147 Philippineswound Care Biologics, By End User, 2016-2025, (Usd Million)
Table 148 Rest Of Asia-Pacific Wound Care Biologics, By Product Type, 2016-2025, (Usd Million)

LIST OF FIGURES

Figure 1 Asia-Pacific Wound Care Biologics Market: Segmentation
Figure 2 Asia-Pacific Wound Care Biologics Market: Data Triangulation
Figure 3 Asia-Pacific Wound Care Biologics Market: Research Snapshot
Figure 4 Asia-Pacific Wound Care Biologics Market: Bottom Up Approach
Figure 5 Asia-Pacific Wound Care Biologics Market: Top Down Approach
Figure 6 Asia-Pacific Wound Care Biologics Market: Interview Demographics
Figure 1 Asia-Pacific Wound Care Biologics Market: Dbmr Market Position Grid
Figure 2 Asia-Pacific Wound Care Biologics Market: The Market Challenge Matrix
Figure 3 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Wound Care Biologics Market
Figure 4 Aging Population In Different Countries (2014, 2017 & 2020)
Figure 5 Asia-Pacific Wound Care Biologics Market: Segmentation
Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Asia-Pacific Wound Care Biologics In The Forecast Period 2018 To 2025
Figure 7 Synthetic Skin Grafts In Asia-Pacific Wound Care Biologics Is Expected To Account For The Largest Share Of The Asia-Pacific Wound Care Biologics Market In 2018 & 2025
Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Asia-Pacific Wound Care Biologics Market In The Forecast Period From 2018 To 2025
Figure 9 Worldwide Prevalence Of Various Wound Types, 2011
Figure 10 Cases Of Burn Injuries, (2009 – 2012)
Figure 11 Prevalence Of Pressure Ulcers In Few Countries
Figure 12 Number Of Surgical Procedures And Surgical Site Infections
Figure 13 Asia-Pacific Wound Care Biologics Market: By Product Type, 2017
Figure 14 Asia-Pacific Wound Care Biologics Market: By Wound Type, 2017
Figure 15 Asia-Pacific Wound Care Biologics Market: By End User, Snapshot 2017
Figure 16 Asia-Pacific Wound Care Biologics Market: Snapshot (2017)
Figure 17 Asia-Pacific Wound Care Biologics Market: By Country (2017)
Figure 18 Asia-Pacific Wound Care Biologics Market: By Country (2018 & 2025)
Figure 19 Asia-Pacific Wound Care Biologics Market, By Country (2017 & 2025)
Figure 20 Asia-Pacific Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 21 Asia-Pacific Wound Care Biologics Market: Company Share 2017 (%)


More Publications